Survey
* Your assessment is very important for improving the workof artificial intelligence, which forms the content of this project
* Your assessment is very important for improving the workof artificial intelligence, which forms the content of this project
8/25/2015 Opioid Safe Prescribing: Intro to the TN Guidelines Steven J Baumrucker, MD, FAAHPM, FAAFP Associate Editor in Chief, The American Journal of Hospice and Palliative Medicine Assistant Clinical Professor, ETSU College of Medicine, LMU/DCOM College of Osteopathic Medicine System Medical Director, Hospice and Palliative Medicine, Wellmont Health System • Timely and appropriate treatment for pain • Improves • Ability to function • Quality of life • Intended to support clinicians in treatment of chronic pain • Avoiding • Addiction • Adverse outcomes Purpose of the Guidelines • MEDD • PO “Morphine Equivalent Daily Dose” • CSMD • “Controlled Substances Monitoring Database” Some Baseline Information 1 8/25/2015 • Defined as pain lasting longer than 90 days • Requires and interdisciplinary process • Many non-opioid modalities • Physical therapy • Psychology • Non opioid medications • Steroids • Anticonvulsants • Antidepressants • SNRI Chronic Pain • In 2011, TN was second in the country for opioid scrips • Unintentional overdose • Increased 250% from 2001 to 2011 • Eclipsed MVA, Homicide, Suicide in 2010 • Neonatal Abstinence Syndrome grew 10-fold 2001-2011 • Five fold increase in Worker’s Comp cases for opioid abuse • Chronic pain still needs treatment • 116 million US adults suffer from chronic pain Why Is This Necessary? • Acute and chronic pain • Among the most common reasons • For physician visits • For taking medication • For work disability • Affects • physical and mental functioning • Quality of life • Productivity Pain 2 8/25/2015 Porter and Jick Letter 3 8/25/2015 • Opioid Addiction is “rare in pain patients” • Physicians allow patients to suffer needlessly because of “opiophobia” • Opioids are safe and effective for chronic pain • Opioid therapy can be easily discontinued Industry Influenced “Education” 5th Vital Sign 4 8/25/2015 Rate of Rx Painkiller Sales, Deaths and Substance Abuse Treatment Admissions (1999-2010) Source: National Vital Statistics System • Top 1% of States that sell prescription pain medications • Top 10 for deaths by overdose • Unintentional Drug overdose • Number one cause of death in TN • Over motor vehicle accidents, homicides • Peak age 40-49 • Providers prescribed 17 opioid scrips per capita • National average=12 TN Ranks Highly in… 5 8/25/2015 • • • • • Improve Symptoms Improve Functioning Improve Quality of Life Minimize adverse effects, including death Minimize addiction Long Term Goals of Pain Management • Not applicable to • • • • End of life care Acute pain Emergency Room Hospital Patients • Not meant to • Dictate medical decision-making • “Generally Accepted” guidelines and not “absolutes” • Providers have flexibility to deal with exceptional cases • “Occasional deviation for appropriate reasons is to be expected” What the Guides are Not • Prescription by another provider is not a reason to continue opioids • Reasonable non-opioid treatments should be tried • All newly pregnant women should have UDS • Discuss birth control to prevent unintended pregnancy in every woman of child-bearing age • Document Hx, PE, Database prior to starting opioids • “Chronic pain shall not be treated [with opioids] through telemedicine.” Key Principles 6 8/25/2015 • H&P • Nature, intensity, past and current Rx • Comorbid conditions • Effect on FUNCTION • • • • Work Relationships Sleep Recreation Initial Steps Prior to Opioid Therapy • Evaluate for conditions that may result in adverse events • • • • • • Age COPD OSA DM CHF Renal Failure • Morphine Co-Morbid Conditions • Initial, condition-appropriate physical exam • Confirm diagnosis? Physical Exam 7 8/25/2015 • Consider screening for • Depression • Anxiety • Current or past substance abuse • Address these in the treatment plan Screening for Mental Health • Scoring: Count the points and total the score. • The possible range is 0-27. • Minimal depression 0-4 may not need depression treatment • Mild depression 5-9 Physician uses clinical judgment • Moderate depression 10-14 Physician uses clinical judgment • Moderately severe depression 15-19 • Severe depression 20-27 Warrants treatment for depression, using antidepressant, psychotherapy and/or a combination of treatment. Scoring the PHQ-9 8 8/25/2015 • Will be addressed later today! Risk Assessment Tools • Review of prior records DIRECTLY RELATED to patient’s CHRONIC PAIN CONDITION • Just saying “I have arthritis” is not sufficient • Prescribers have had difficulty justifying some diagnoses before the BME • “Well, they TOLD me they had cancer.” • Remember, another prescriber writing pain medications is not in itself justification to continue them Records Review • Women of child-bearing age and reproductive capacity • Should be asked about the possibility of pregnancy at each visit • Use of contraception should be discussed • Referral to high risk OBGYN considered • (We’ll cover “Women’s Issues” later in the day) Pain Medications and Pregnancy 9 8/25/2015 • “There shall be the establishment of a current diagnosis that justifies a need for opioid medications.” Establish a Diagnosis • “The prescriber shall assess the patient’s risk for misuse, abuse, diversion and addiction.” • The prescriber should obtain a urine drug screen • The prescriber shall check the Controlled Substances Database (tncsmd.com) • The prescribing of opioids shall take risk assessment information into account Assessment of Risk for Abuse • Primary goal of treatment should be clinically significant improvement in function. • Treatment plan must also • Include other treatments beyond opioids • Pharmacological and non-pharmacological • Provider should make reasonable attempts to implement this plan • Counsel the patient • Goal is to increase function and reduce pain • NOT eliminate pain • “documentation of this discussion shall be included in the medical record.” Goals for Treatment 10 8/25/2015 Initiating Opioids For Management of Chronic Non-Malignant Pain • Maximum of 4 breakthrough doses/day • If more are needed, simply document why • Methadone shall be prescribed only by a pain medicine specialist • Prescribers shall not prescribe buprenorphine for chronic pain • If opioid >= 120mg PO Morphine Equivalents/day • A mental health professional must assess necessity for any concomitant benzodiazepine prescriptions • Should treatment deviate from the guidelines • Simply document the reasons in the medical record Key Principles • Short acting • • • • Incident pain Acute pain Short-term treatment Mild pain • Long acting • Less of a peak effect • Chronic pain requiring round the clock dosing • ONE long-acting, ONE short-acting • Short-acting MEDD should never be more than 50-100% of the long-acting. Basics of Opioid Therapy 11 8/25/2015 • Sustained release Morphine • 30mg PO BID • Breakthrough dose • Immediate Release morphine • 7.5 – 15mg PO QID prn • LA = 60 MEDD • SA = 30-60 MEDD Example Morphine Oxycodone Oxymorphone Hydromorphone Calculating MEDD • Patient is on Opana ER 20mg PO BID and Hydromorphone 4mg PO QID prn • MEDD= • 40mg PO OPANA x 30mg PO Morphine/10mg PO Opana • = 120mg PO Morphine/day • 16 mg PO dilaudid x 30mg PO Morphine/7.5mg PO dilaudid • = 64mg PO Morphine/day • TOTAL MEDD • = 64+120 = 184 mg PO Morphine/day Example 12 8/25/2015 • Initiation should be presented as a therapeutic trial • Opioid naïve? • Use lowest dose and titrate to effect • INFORMED CONSENT must be obtained • • • • • See sample informed consent Risks, alternatives and benefits Likelihood of dependence, risk of oversedation Pregnancy Risk of impaired motor skills, addiction and death • Written treatment agreement Upon Initiating Opioids • • • • • • Reasons for discontinuation of controlled substances Practice policy on “early refills” Policy on lost prescriptions Use of one pharmacy Periodic drug testing Female patients will tell the provider if they want to avoid unintended pregnancy and if they become pregnant • See sample treatment agreement Written Treatment Agreement • Practitioners may provide a bridge of opioids • For up to 6 months • While assessment process is carried out • No provider is obligated to continue opioid therapy that has been initiated by another provider • If the initial evaluation does not support opioid use • Discussion about risk and possible treatment of withdrawal • Document with clinical reasoning for cessation Opioid Bridge 13 8/25/2015 • Providers must continually monitor patients for signs of • • • • Abuse Misuse Diversion Improvement of underlying condition • Document improvement in • Physical Functioning • Psychosocial Functioning • Drug Screening should be done twice a year (minimum) Reassessment Treatment with Opioids Key principles • • • • • Chronic opioid therapy should be handled by a single provider Prescriptions should be filled in a single pharmcy Use the lowest effective dose NO MORE THAN ONE SHORT-ACTING OPIOID Document “The Five As” • • • • • Analgesia Activities of Daily Living Adverse effects Aberrant behavior Affect Key Principles 14 8/25/2015 • State recommends that patients on >100 MEDD should be referred to a pain specialist • Consultation vs management • If not done, document why • Monitor patients for abuse • • • • UDS at least twice a year Document pill counts Check the CSMD Ongoing risk assessment • Stop opioid therapy if the risks outweigh the benefits • Taper if indicated Ongoing Therapy • Any time the risks outweigh the benefits therapy should be discontinued • Discontinuation poses risk for withdrawal • Nausea, vomiting, piloerection, diaphoresis, myalgia • Acute post withdrawal syndrome • Depression, malaise, fatigue, lasting up to two YEARS • Benzodiazepine withdrawal can be fatal • Low dose opioids low risk for withdrawal • Responsibility of the current provider to address this issue Tapering Protocol • Conservative: • 10% reduction per week • Moderate • 25% reduction every 4 days • Aggressive • 25-50% reduction daily • TN Dept of Health does not recommend any specific protocol • Adjuvant medication • Clonidine 0.1mg q6h or 0.1mg TD q24h • Hypotension and anticholinergic effects Weaning Opioids 15 8/25/2015 • If recent UDS shows no opioids in system weaning is not necessary • If drug diversion is suspected, further prescribing is not indicated. • If any circumstance is thought to constitute more risk to the patient or community than the potential for withdrawal, no additional opiates should be prescribed. REMEMBER Applicable TN Statutes • If detected, provider must report to law enforcement • Form is located at: • http://bit.ly/1bPjSiT • • • • Fax directly to 423 267 8983 Or scan and email to: [email protected] Simply starts a process Enters patient into a database looking for other “red flags” Doctor Shopping 16 8/25/2015 • No specific penalty for failing to report. • Protection from liability • A health care provider, or any person under the direction of the health care provider or any entity that assumes the responsibility of reporting for the provider who furnishes any information in good faith is immune from liability if a complaint, report, information, or record is furnished to a law enforcement agency.” • item (d) in 53-11-309. Penalty for Not Reporting (TN Guidelines) • TennCare has its own rules, however • “All managed care …providers …shall advise the office of TennCare inspector general immediately when …fraud is being…committed.” • Any person … making a complaint … is immune from civil liability. • Providers …shall advise the Medicaid fraud control unit (MFCU) • “…failure to report such fraud shall be subject to a civil penalty of not more than ten thousand dollars ($10,000) for each finding to be assessed by the office of TennCare inspector general.” Reporting “Fraud” for TennCare Patients 17 8/25/2015 • “…knowingly, willfully and with the intent to deceive, failing to disclose to a … health care provider …that the person has received either the same controlled substance or a prescription for the same controlled substance, or a controlled substance of similar therapeutic use …from another practitioner within the previous thirty (30) days and the person used TennCare to obtain the benefits.” Definition of Fraud in this Context -- (TennCare) Tennessee Laws • The TNBME does not have a list of “bad” drugs • Nor a “magic formula” for dosage/admin • Does have an expectation of the following • • • • Proper indication Monitoring Follow up, reassessment Rationale for continuing or modifying therapy No “Bad” Drugs 18 8/25/2015 • Pain patient’s bill of rights • Does NOT apply to acute pain Rx • Right to opiates IF patient, physician concur • Medically necessary dose of opiates may be used • Defense to disciplinary action by board • Physician right to prescribe even for abusers, addicts for pain • REPEALED by House and Senate in 2015 Intractable Pain Act 2001 • Effective January 1, 2012, all pain management clinics must be registered with the State. • Link to application: http://health.state.tn.us/Downloads/PH4151.pdf • Link to rules: http://state.tn.us/sos/rules_all/2011/1200-3401.20110930.pdf Pain Management Clinics • privately-owned facility • provides pain management services to patients • majority of whom are issued a prescription for opioids, benzodiazepine, barbiturates, or carisoprodol, for more than 90 days within 12-month period • Does not include suboxone (separate requirements) Do you need to register? 19 8/25/2015 • • • • • • • (1) A medical or dental school (2) A hospital including any outpatient facility or clinic of a hospital; (3) Hospice services as defined in S 68-1 1-201; (4) A nursing home as defined in S 68-11-201; (5) A facility maintained or operated by this state; or (6) A hospital or clinic maintained or operated by the federal government. Does Not Apply To Practitioners at uncertified clinics may be fined $1000 per day by their board Clinic itself can be fined $1000 a day for not meeting legal requirements Inspections/Complaints • [email protected] • 423 923 1522 Contact Dr Baumrucker 20